Literature DB >> 7494038

In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae.

K L Godzik1, E R O'Brien, S K Wang, C C Kuo.   

Abstract

Chlamydia pneumoniae is a common respiratory pathogen. Recent studies have demonstrated the presence of C. pneumoniae in coronary and aortic atherosclerotic lesions. To study the role of C. pneumoniae in atherosclerosis, we investigated the susceptibilities of three different cells of the human vascular wall to infection with C. pneumoniae AR-39. These cell types were endothelial cells, smooth muscle cells, and macrophages derived from peripheral blood monocytes. Infection was assessed by using a direct fluorescent antibody to assess inclusion counts. Duplicate cell samples were harvested 3 days postinfection and were passed in HL cells, a susceptible human epithelial cell line, to determine if infectious organisms were produced. Endothelial cells, smooth muscle cells, and macrophages were capable of supporting C. pneumoniae growth in vitro. These results showed that three different cell types known to be important in atherogenesis are susceptible to infection with C. pneumoniae.

Entities:  

Mesh:

Year:  1995        PMID: 7494038      PMCID: PMC228425          DOI: 10.1128/jcm.33.9.2411-2414.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

2.  Differential antimicrobial activity of human mononuclear phagocytes against the human biovars of Chlamydia trachomatis.

Authors:  E C Yong; E Y Chi; C C Kuo
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

Review 3.  Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes.

Authors:  D P Hajjar
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

4.  Chlamydia trachomatis-induced production of interleukin-1 by human monocytes.

Authors:  C D Rothermel; J Schachter; P Lavrich; E C Lipsitz; T Francus
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

5.  Development of intimal lesions after leukocyte migration into the vascular wall.

Authors:  M F Prescott; C K McBride; M Court
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

6.  Chlamydia pneumoniae multiplies in human endothelial cells in vitro.

Authors:  S S Kaukoranta-Tolvanen; K Laitinen; P Saikku; M Leinonen
Journal:  Microb Pathog       Date:  1994-04       Impact factor: 3.738

7.  A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  J Infect Dis       Date:  1990-09       Impact factor: 5.226

Review 8.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

9.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; J T Grayston; D S Siscovick; S P Wang; N S Weiss; J R Daling
Journal:  JAMA       Date:  1992-07-01       Impact factor: 56.272

10.  Effects of lipopolysaccharide on human endothelial cells in culture.

Authors:  J M Harlan; L A Harker; G E Striker; L J Weaver
Journal:  Thromb Res       Date:  1983-01-01       Impact factor: 3.944

View more
  42 in total

1.  Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

2.  Cell-mediated immune response during primary Chlamydia pneumoniae infection.

Authors:  S Halme; J Latvala; R Karttunen; I Palatsi; P Saikku; H M Surcel
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 3.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

4.  Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.

Authors:  L G Pantoja; R D Miller; J A Ramirez; R E Molestina; J T Summersgill
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-06       Impact factor: 3.725

6.  Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection.

Authors:  Jessica B Sakash; Gerald I Byrne; Andrew Lichtman; Peter Libby
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

7.  Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor.

Authors:  Mikael M Cornelsen Gencay; Michael Tamm; Allan Glanville; André P Perruchoud; Michael Roth
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

8.  Chlamydia pneumoniae infection in polarized epithelial cell lines.

Authors:  Liisa Törmäkangas; Eveliina Markkula; Kari Lounatmaa; Mirja Puolakkainen
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

9.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

Review 10.  Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis.

Authors:  Satoru Hirono; Grant N Pierce
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.